Expression of cell cycle‐regulated genes and prostate cancer prognosis in a population‐based cohort

R Rubicz, S Zhao, C April, JL Wright, S Kolb… - The …, 2015 - Wiley Online Library
BACKGROUND Prostate cancer (PCa) is clinically and biologically heterogeneous, making
it difficult to predict at detection whether it will take an indolent or aggressive disease course …

Expression of cell cycle-regulated genes and prostate cancer prognosis in a population-based cohort

R Rubicz, S Zhao, C April, JL Wright, S Kolb, I Coleman… - Prostate, 2015 - hero.epa.gov
BACKGROUND: Prostate cancer (PCa) is clinically and biologically heterogeneous, making
it difficult to predict at detection whether it will take an indolent or aggressive disease course …

Expression of cell cycle-regulated genes and prostate cancer prognosis in a population-based cohort

R Rubicz, S Zhao, C April, JL Wright… - …, 2015 - mdanderson.elsevierpure.com
BACKGROUND Prostate cancer (PCa) is clinically and biologically heterogeneous, making
it difficult to predict at detection whether it will take an indolent or aggressive disease course …

Expression of cell cycle-regulated genes and prostate cancer prognosis in a population-based cohort

R Rubicz, S Zhao, C April, JL Wright, S Kolb… - The …, 2015 - pubmed.ncbi.nlm.nih.gov
Background Prostate cancer (PCa) is clinically and biologically heterogeneous, making it
difficult to predict at detection whether it will take an indolent or aggressive disease course …

[HTML][HTML] Expression of Cell Cycle-regulated Genes and Prostate Cancer Prognosis in a Population-based Cohort

R Rubicz, S Zhao, C April, JL Wright, S Kolb… - The Prostate, 2015 - ncbi.nlm.nih.gov
BACKGROUND Prostate cancer (PCa) is clinically and biologically heterogeneous, making
it difficult to predict at detection whether it will take an indolent or aggressive disease course …

Expression of cell cycle-regulated genes and prostate cancer prognosis in a population-based cohort.

R Rubicz, S Zhao, C April, JL Wright, S Kolb… - The Prostate, 2015 - europepmc.org
Background Prostate cancer (PCa) is clinically and biologically heterogeneous, making it
difficult to predict at detection whether it will take an indolent or aggressive disease course …